ClinicalTrials.govpublic full text
AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV
hiv infections, human immunodeficiency virus, anti-retroviral therapy, nucleoside analogue, reverse transcriptase, lamivudine, resistance mutation, treatment experienced, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 868132
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.